TNGX

TNGX Operating Income Growth

13.31%TTM

Period ending:

TNGX TTM Operating Income YoY %%
TNGX TTM Operating Income YoY %41.63%-145.10%
2021-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

TNGX operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 19 observations from Dec 31, 2021 to Jun 30, 2026.

Tango Therapeutics Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
13.3128%
19.4296%
23.5626%
21.0189%
-18.7541%
-15.6404%
-27.5225%
-27.3153%
-16.1573%
-8.7629%
-2.7919%
-7.0623%
-23.7578%
-62.2342%
-90.8764%
-127.0246%
-76.0601%
-27.1621%
-11.473%

Compare operating income growth

All TNGX financial metrics · TNGX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.